Veto Process
No veto information available
Boeckligomes
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Ririi1 | 281 | 23 / 17 / 8 | 180 | 83% | 3 - 1 | 11% |
| Clotildeee | 224 | 20 / 15 / 6 | 154 | 75% | 1 - 3 | 29% |
| Evoxia | 246 | 20 / 19 / 6 | 170 | 79% | 4 - 4 | 25% |
| Vichyx | 177 | 16 / 15 / 1 | 120 | 67% | 4 - 2 | 24% |
| sweazee | 167 | 14 / 14 / 10 | 105 | 67% | 2 - 0 | 17% |
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| Ririi1 | 281 | 23 / 17 / 8 | 180 | 83% | 3 - 1 | 11% |
| Clotildeee | 224 | 20 / 15 / 6 | 154 | 75% | 1 - 3 | 29% |
| Evoxia | 246 | 20 / 19 / 6 | 170 | 79% | 4 - 4 | 25% |
| Vichyx | 177 | 16 / 15 / 1 | 120 | 67% | 4 - 2 | 24% |
| sweazee | 167 | 14 / 14 / 10 | 105 | 67% | 2 - 0 | 17% |
Boeckligomes
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Ririi1 | 281 | 23 / 17 / 8 | 180 | 83% | 3 - 1 | 11% |
|
Clotildeee | 224 | 20 / 15 / 6 | 154 | 75% | 1 - 3 | 29% |
|
Evoxia | 246 | 20 / 19 / 6 | 170 | 79% | 4 - 4 | 25% |
|
Vichyx | 177 | 16 / 15 / 1 | 120 | 67% | 4 - 2 | 24% |
|
sweazee | 167 | 14 / 14 / 10 | 105 | 67% | 2 - 0 | 17% |
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
Ririi1 | 281 | 23 / 17 / 8 | 180 | 83% | 3 - 1 | 11% |
|
Clotildeee | 224 | 20 / 15 / 6 | 154 | 75% | 1 - 3 | 29% |
|
Evoxia | 246 | 20 / 19 / 6 | 170 | 79% | 4 - 4 | 25% |
|
Vichyx | 177 | 16 / 15 / 1 | 120 | 67% | 4 - 2 | 24% |
|
sweazee | 167 | 14 / 14 / 10 | 105 | 67% | 2 - 0 | 17% |